Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives and methods

BACKGROUND: Cognitive side-effects are an important reason for the limited use of electroconvulsive therapy (ECT). Cognitive side-effects are heterogeneous and occur frequently in older persons. To date, insight into these side-effects is hampered due to inconsistencies in study designs and small sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Henstra, Marieke J., Feenstra, Thomas C., Kok, Rob M., Spaans, Harm-Pieter, van Exel, Eric, Dols, Annemiek, Oudega, Mardien, Vergouwen, Anton C. M., van der Loo, Adriano, Bet, Pierre M., Loer, Stephan A., Eikelenboom, Merijn, Sienaert, Pascal, Lambrichts, Simon, Bouckaert, Filip, Bosmans, Judith E., van der Velde, Nathalie, Beekman, Aartjan T. F., Stek, Max L., Rhebergen, Didi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334653/
https://www.ncbi.nlm.nih.gov/pubmed/35911242
http://dx.doi.org/10.3389/fpsyt.2022.953686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334653/
https://www.ncbi.nlm.nih.gov/pubmed/35911242
http://dx.doi.org/10.3389/fpsyt.2022.953686

Ejemplares similares